# Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections

> **NCT05376566** · NA · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 212 (actual)

## Conditions studied

- Central Line-associated Bloodstream Infection (CLABSI)

## Interventions

- **DRUG:** Hydrochloric Acid (2 M)
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT05376566
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-03-01
- **Target enrollment:** 212 (ACTUAL)
- **Last updated:** 2026-03-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376566, "Hydrochloric Acid Lock Therapy for Central Line-associated Bloodstream Infections". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05376566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*